Background: Concern has been raised that early detection of lung cancer may lead to the
treatment of clinically indolent cancers. No population-based study has examined the …

BACKGROUND Skepticism about the radical curability of lung carcinoma, even when
diagnosed in Stage I, has been long fostered by the epidemiologists' dogma against lung …

BACKGROUND: The core strategy of American College of Chest Physicians lung cancer
guidelines is identification of the earliest symptoms of lung cancer and the immediate …

Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of
patients with differences in the extent and localization of disease. Many aspects of stage III …

Background Standard therapy for metastatic non small cell lung cancer (NSCLC) includes
palliative systemic chemotherapy and/or radiotherapy. Recent studies of patients with limited …

Study objectives To assess the treatments received and outcomes of patients with early
stage non-small cell lung carcinoma (NSCLC). Design A retrospective study of patients …

BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to
provide a survival benefit in patients with resected stage I nonsmall cell lung cancer …

Background Although there has been a significant survival improvement for patients with
metastatic NSCLC enrolled in randomized trials, it is not clear whether a similar benefit is …

Background The benefits of screening for non-small cell lung cancer (NSCLC) have been
established for high-risk individuals, and recent guidelines advocate continued surveillance …

Background The purpose of this study was to evaluate the risk of late recurrence in patients
who had undergone complete resection for non-small cell lung cancer (NSCLC) and …